These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 923462)

  • 1. [The drug security system of physicians].
    Kimbel H
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1784-5. PubMed ID: 923462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physician's responsibility for the comprehension of adverse drug reactions].
    Kimbel KH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1550-8. PubMed ID: 611878
    [No Abstract]   [Full Text] [Related]  

  • 3. [Information of the World health organization on adverse effects and contraindications of various drugs].
    Navrátil K; Buriánek J
    Cas Lek Cesk; 1970 Jan; 109(4):94-5. PubMed ID: 5412528
    [No Abstract]   [Full Text] [Related]  

  • 4. International aspects of drug monitoring. Role of the World Health Organization.
    Royall BW
    WHO Chron; 1971 Oct; 25(10):445-51. PubMed ID: 5131672
    [No Abstract]   [Full Text] [Related]  

  • 5. The Swedish drug monitoring system.
    Westerholm B
    World Health Organ Tech Rep Ser; 1972; 498():26-36. PubMed ID: 4625549
    [No Abstract]   [Full Text] [Related]  

  • 6. [International cooperation in assembling adverse drug effects. A scientific trial program as a pilot study of the World Health Organization].
    Homann G
    Zahnarztl Mitt; 1968 Jul; 58(13):635-6. PubMed ID: 5243097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Professional secrecy among attending physicians].
    Rieger HJ
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1785-6. PubMed ID: 923463
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring adverse reactions to drugs.
    Royall BW
    WHO Chron; 1973 Nov; 27(11):469-75. PubMed ID: 4756663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection and prevention of drug-induced lesions. 20 years' experiences in the Drug Committee of the German Medical Society].
    Homann G
    Internist (Berl); 1973 Jan; 14(1):19-24. PubMed ID: 4576792
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of computers in international drug monitoring.
    WHO Chron; 1973 Nov; 27(11):476-80. PubMed ID: 4756664
    [No Abstract]   [Full Text] [Related]  

  • 11. International drug monitoring: the role of national centres. Report of a WHO meeting.
    World Health Organ Tech Rep Ser; 1972; 498():1-25. PubMed ID: 4625548
    [No Abstract]   [Full Text] [Related]  

  • 12. [Information on drugs and the risk of drugs. Staged project for the coordination of measures].
    Kimbel KH
    Med Klin; 1976 Feb; 71(9):390. PubMed ID: 1256339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liability for drug damages].
    Barnikel W
    Dtsch Med Wochenschr; 1977 Jan; 102(4):139. PubMed ID: 832595
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacist-community nurse liaison services.
    White SJ; Godwin HN
    Am J Hosp Pharm; 1974 Nov; 31(11):1063-5. PubMed ID: 4432856
    [No Abstract]   [Full Text] [Related]  

  • 15. [To what extent is the physician responsible for adverse effects of drugs?].
    Trube-Becker E
    Med Klin; 1980 Jun; 75(13):496-8. PubMed ID: 7412700
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibilities and limits of drug supervision].
    Homann G
    Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacist and physician evaluation of drug information sources.
    Harelik JH; Johnston PM; Rivers NP; Ryan MR
    Am J Hosp Pharm; 1975 Jun; 32(6):594-7. PubMed ID: 1155473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Position and significance of the public health physician within the medical-society from the public health physicians' viewpoint].
    Böhm A
    Offentl Gesundheitswes; 1973 Dec; 35(3):Suppl 3:138-42. PubMed ID: 4273972
    [No Abstract]   [Full Text] [Related]  

  • 19. [Registration, collection, and evaluation of drug side effects. Subsequent control necessary for drug security].
    Stockhausen J
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):460-3. PubMed ID: 5046056
    [No Abstract]   [Full Text] [Related]  

  • 20. The planning of a national drug monitoring system.
    Esch AF
    World Health Organ Tech Rep Ser; 1972; 498():44-7. PubMed ID: 4625551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.